2006
DOI: 10.1002/cmdc.200600006
|View full text |Cite
|
Sign up to set email alerts
|

The Nuclear Receptor Superfamily and Drug Discovery

Abstract: Targeting the nuclear receptors: The ligand‐binding domain of the glucocorticoid receptor (ribbon) bound with the ligand, dexamethasone (space‐filling) is just one of the many pictures that are becoming clearer in the field of nuclear receptor (NR) research. Recent developments in drug discovery show great promise for the treatment of many NR‐related diseases.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
64
0
1

Year Published

2010
2010
2021
2021

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 139 publications
(67 citation statements)
references
References 131 publications
1
64
0
1
Order By: Relevance
“…NR signaling involves ligand-triggered protein-protein interaction to assemble a multiprotein complex that regulates transcription in response to hormone binding (2,55,56). Structurally, NRs interact with coactivators through similar surfaces, with a shallow hydrophobic groove on the surface binding to an amphipathic ␣-helical motif on the coactivator, burying the three leucines into the hydrophobic surface of the NR box (26,27).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…NR signaling involves ligand-triggered protein-protein interaction to assemble a multiprotein complex that regulates transcription in response to hormone binding (2,55,56). Structurally, NRs interact with coactivators through similar surfaces, with a shallow hydrophobic groove on the surface binding to an amphipathic ␣-helical motif on the coactivator, burying the three leucines into the hydrophobic surface of the NR box (26,27).…”
Section: Discussionmentioning
confidence: 99%
“…The nuclear hormone receptors (NR) 2 are transcription factors that are a major focus for drug development in the pharmaceutical industry for diverse diseases including metabolic disease, immunology, reproductive health, and cancer (1)(2)(3). Most NR modulators are ligand analogs; tamoxifen (4) and faslodex (5) bind the estrogen receptor (ER), hydroxyflutamide (6) and bicalutamide (7,8) target the androgen receptor (AR), and rosiglitazone (9,10) and pioglitazone (11,12) bind the peroxisome proliferator-activated receptor ␥ (PPAR␥).…”
mentioning
confidence: 99%
“…Ligand activation of NRs induces an active conformation, enabling transcriptional regulation (Moore et al 2006). Within the NR superfamily, two modes of action exist.…”
Section: Introductionmentioning
confidence: 99%
“…5,6 Physiological effects of progesterone are mediated by multiple mechanisms of action; mainly through the activation of the progesterone receptor (PR), 7 a member of the oxosteroid receptor family (oSR), which also includes receptors for the mineralocorticoids (MR), glucocorticoids (GR) and androgens (AR). 8 The oSRs are soluble intracellular proteins that act mainly as ligand regulated transcription factors, regulating specific gene expression in most mammalian cells. 9 Structurally, oSRs are modular proteins organized into three major domains: an N-terminal activation function-1 (AF-1), a central DNA binding domain (DBD) and a C-terminal ligand binding domain (LBD).…”
Section: Introductionmentioning
confidence: 99%